Select a Topic

Featured Articles

Cardiovascular Forum

• Television Viewing Time and Mortality. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab).—Circulation 2010 1;():
• Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.—Circulation 2010 1;121(1):110-22
• Forecasting the effects of obesity and smoking on U.S. life expectancy.—N Engl J Med 2009 12;361(23):2252-60

Diabetes Forum

• Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.—Diabet Med 2009 11;26(11):1147-55
• A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).—Am J Med 2009 11;122(11):1043-9
• Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.—Int J Clin Pract 2009 9;63(9):1395-406

Growth Forum

• Depressive tendency in children with growth hormone deficiency.—J Paediatr Child Health 2009 11;45(11):636-40
• Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety.—J Clin Endocrinol Metab 2009 6;94(6):2052-9
• Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.—Eur J Endocrinol 2009 5;160(5):719-29

Nephrology Forum

• Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults.—J Am Soc Nephrol 2009 8;20(8):1823-32
• Intensity of continuous renal-replacement therapy in critically ill patients.—N Engl J Med 2009 10;361(17):1627-38

Rheumatology Forum

• Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.—Arthritis Rheum 2009 12;62(1):22-32
• Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.—Lancet 2009 8;374(9688):459-66
• Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.—Lancet 2009 4;373(9671):1253-63

Oncology Forum

• Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.—J Womens Health (Larchmt) 2009 3;18(3):311-9
• Adjuvant chemotherapy in older women with early-stage breast cancer.—N Engl J Med 2009 5;360(20):2055-65
• Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.—N Engl J Med 2009 4;360(14):1408-17

Primary Care Forum

• Television Viewing Time and Mortality. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab).—Circulation 2010 1;():
• Trajectories of entering the metabolic syndrome: the framingham heart study.—Circulation 2009 11;120(20):1943-50
• Effects of Colesevelam HCl, Rosiglitazone, or Sitagliptin on Glycemic Control and the Lipid Profile in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy.—Endocr Pract 2009 9;():1-34

Stay on Top of Major Advances

Now access BioCritique directly from Facebook!

Featured BioDiscussion